Cordis……

Since its founding in 1959, Cordis Corporation has dedicated its resources to improve the quality of life.

As a world leader in medical technologies our technical and market strengths encompass the whole of circulatory disease management.

The heart has been Cordis area of expertise since 1959, when the company was founded. Our tradition of innovation was evidenced when Cordis introduced the first cardiovascular stent for the elective treatment of coronary and the first disposable catheters. Today, Cordis tradition of innovation continues just as our commitment to cardiology remains as strong as today as it was forty years ago.

Cordis is committed to being the global leader in innovative treatments for vascular and obstructive diseases to improve patients care outcomes. 

Cordis interventional neuroradiology products make it possible to perform minimally invasive procedures to treat the vasculature of the brain and the head.

Biosense Webster brings new and innovative products and services, that solve problems facing electrophysiologists, cardiologists and their patients. For more than thirty years, the name Webster has been synonymous with advancing the design of diagnostic and therapeutic cardiac catheters. The unique Biosense easy-to-use navigation systems offer an unprecedented view into the working of the heart. 

CORDIS 

a division of Johnson & Johnson AG

Rotzenbuehlstrasse 55

CH-8957 Spreitenbach